Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06133088
Status:
RECRUITING
Last Update Posted:
2023-11-15
First Post:
2023-10-31
Brief Title:
Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK46 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer a Phase 2 Clinical Trial
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-31
First Submit QC Date:
November 9 2023
Study First Post Date:
2023-11-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-09
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL